Loading clinical trials...
Loading clinical trials...
A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy in US Patients With Cystic Fibrosis Treated With Pancreatic Enzyme Replacement Therapy: A Harmonized Protocol Across Sponsors(The CF-FC Study)
Conditions
Interventions
ULTRESA
PANCREAZE
+5 more
Locations
123
United States
Children's Hospital of Alabama /ID# 78920
Birmingham, Alabama, United States
Alaska Medical Center /ID# 79256
Anchorage, Alaska, United States
Phoenix Children's Hospital /ID# 78906
Phoenix, Arizona, United States
University of Arizona Cancer Center - North Campus /ID# 78939
Tucson, Arizona, United States
Arkansas Children's Hospital /ID# 79265
Little Rock, Arkansas, United States
University of Arkansas for Medical Sciences /ID# 76785
Little Rock, Arkansas, United States
Start Date
July 31, 2012
Primary Completion Date
April 8, 2020
Completion Date
April 8, 2020
Last Updated
March 22, 2021
Lead Sponsor
AbbVie
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions